Navigation Links
Pharmalink AB Closes Deal With Grifols SA for the Acquisition of the Xepol(R) Programme for the Treatment of Post-Polio Syndrome
Date:6/30/2010

, non-fatiguing exercise and the use of assistive devices. The promising results with immunoglobulin may help address the unmet medical need of some PPS patients. In several clinical trials lead by a team of physicians at Karolinska Institutet (Sweden) and sponsored by Pharmalink AB, immunoglobulin has shown significant and clinically meaningful results in endpoints such as pain, walking ability and quality of life (SF-36 scores) by down-regulating the inflammatory process in the nervous system of PPS patients.

About Pharmalink

Pharmalink is a Swedish specialty pharma company developing high value products for niche indications. Pharmalink draws on its extensive experience of pharmaceutical product development and the excellence of medical science in Sweden to identify and progress products that address significant unmet medical needs. Pharmalink has introduced more than 15 pharmaceutical products to the market. Using a repurposing and reformulation strategy, Pharmalink minimizes the risk of product development. The Company's strategy is to develop drugs to clinical proof-of-concept and then to out-license or divest to a commercial partner. Pharmalink currently has two clinical phase development projects, Nefecon(R) and BusulipoTM, mature for out-licensing to a commercial partner and is actively in-licensing promising new projects to add to its pipeline. Visit http://www.pharmalink.se for further information.

About Grifols

Grifols is a Spanish holding company specialized in the pharmaceutical-hospital sector and is pr
'/>"/>

SOURCE Pharmalink AB
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. Pharmalink AB Strengthens its Board of Directors and Signals a Strategic Step Towards Late Phase Product Development
2. Pharmalink AB Completes Phase II Clinical Study With Renal Disease Drug Nefecon(R)
3. OncoVista, Inc. Closes on $6.8 Million Financing and Acquires Control of a Public Shell Company
4. Genmab Discloses Target and Development Plans for HuMax-Inflam
5. Oxford Finance Corporation Closes $7 Million Debt Facility with Othera Pharmaceuticals
6. RoundTable Healthcare Partners Closes Sale of MedAssist Holding, Inc. to Firstsource Solutions Limited
7. Gilde Healthcare Partners Closes EUR 150 Million European Healthcare Venture Fund
8. Symmetry Medical Discloses Accounting Issues at Sheffield, UK Operating Unit and Possible Restatement
9. BioVex Closes Second Round of Series E Financing
10. Pharmaxis Closes Share Purchase Plan
11. The closest look ever at native human tissue
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... , May 17, 2013  Insero Health, Inc., a ... in epilepsy and related neurological disorders, is today reporting ... lead compound INS001 in patients with drug-resistant epilepsy.  The ... Device Trials (AED) Xll meeting by Dr. ... Chairman of Insero,s Scientific Advisory Board.  In this study, ...
(Date:5/17/2013)... 2013 Rust removal is one of home ... items could be damaged. To help rust contractors make it ... no-scrubbing rust remover it called Rusterizer. It announced ... 10% discount. , My Cleaning Products explained that rust could ... by staining them. The first one, it said, happens ...
(Date:5/16/2013)... Tampa, FL (PRWEB) May 16, 2013 ... has named Barbara A. Myers, CAE, to the ... Development. In her new role, Myers will be ... event development and production strategies, advancing the Society’s ... development processes and continuing to refine organizational, membership ...
(Date:5/16/2013)... 16, 2013 Cambridge Healthtech Institute will ... 19-23, 2013 at the Renaissance Waterfront Hotel in Boston, ... a close-up look at the current strategies and innovations ... quality. Leaders in the field will reveal how ... biopharmaceuticals with greater specificity and efficiency. , “In this ...
Breaking Biology Technology:Insero Health Reports Positive Data on Phase I Trial of Novel Therapy for Drug-resistant Epilepsy 2Organic-Based Rust Remover Cuts Down Price by 10%, My Cleaning Products Details Mechanics How to Get the Discount 2ISPE Names Barbara A. Myers, CAE, as Vice President of Professional Development 2The 2013 Bioprocessing Summit to Bring Together International Leaders to Discuss Today's Bioprocess Issues From Cell Line Selection to Manufacturing in Boston, MA 2
... Particle Sciences has expanded,its production capacity by the addition ... room. The space also contains several Class 100 hoods ... 15,000 sq ft facility in response,to the increasing need ... and dispersions. "This,investment is the latest in a series ...
... New Patients Shipped in the Quarter ... Month ... BEDFORD, Mass., May 13 Insulet Corporation,(Nasdaq: PODD ), ... System, today announced financial results for,the first quarter ended March 31, ...
... Victory May 14, 2008 - ... Highline Ballroom, Spring Soiree to Benefit Effort to Protect Seriously Ill New York Patients ... Who Use Medical Marijuana, NEW YORK, May ... and music to benefit MPP,s,efforts to protect seriously ill New Yorkers from arrest and jail ...
Cached Biology Technology:Insulet Reports First Quarter 2008 Results 2Insulet Reports First Quarter 2008 Results 3Insulet Reports First Quarter 2008 Results 4Insulet Reports First Quarter 2008 Results 5Insulet Reports First Quarter 2008 Results 6Insulet Reports First Quarter 2008 Results 7New York Benefit to Celebrate Recent Medical Marijuana Successes 2
(Date:5/17/2013)... Shenzhen, China---- Why Tibetan antelope can live at ... a collaborative research published in Nature Communications ... institutes provide evidence that some genetic factors may ... highland environments. The data in this work will ... and the biology of other ruminant species. , ...
(Date:5/17/2013)... new Dartmouth College study finds human-caused climate change ... tropical lizards, contradicting a host of recent studies ... warming planet. , The findings, which appear in ... new hope for survival of a creature thought ... predictions that tropical cold-blooded animals, especially forest lizards, ...
(Date:5/17/2013)... team of scientists using a new X-ray method recorded ... frog embryo in greater detail than ever before., This ... and the search for new treatments for genetic diseases., ... Technologie in Germany, in collaboration with the Advanced Photon ... Laboratory, released the most precise depiction ever of the ...
Breaking Biology News(10 mins):The genome sequence of Tibetan antelope sheds new light on high-altitude adaptation 2Climate change may have little impact on tropical lizards 2New X-ray method shows how frog embryos could help thwart disease 2
... the key nutrients that can cause algal blooms and ... worldwide. Phosphorus entering waters originates from a variety ... of organic by-products such as animal manure is one ... enriched with P, leading to elevated P loss through ...
... of the best-studied single-celled organisms around, is a master of ... factory with just one product: itself. It exists to make ... them at the lowest possible cost, with the greatest possible ... be defined by the energy and resources it uses to ...
... - Training people to avoid falls by repeatedly exposing ... to later maintain their balance on a slippery floor, ... Neurophysiology . The study furthered the understanding of ... be generalized to a variety of conditions. The research ...
Cached Biology News:Understanding phosphorus in soils is vital to proper management 2Bacteria are models of efficiency 2Research model may one day 'inoculate' elderly against slip-related falls 2Research model may one day 'inoculate' elderly against slip-related falls 3
... White solid. PACKAGED UNDER INERT GAS. DO ... resin with applications similar to those of DTT ... , and 233155 ) but with the ... to the system. REDUCTACRYL™ Reagent can be used ...
... HVJ (hemagglutinating virus of Japan, also named ... tool for transfection of molecules by means ... for siRNA (RNAi), Protein, Oligo, cDNA, Antibodies, ... in vivo. GenomONE-Neo EX has a high ...
... White solid.. PACKAGED UNDER INERT GAS. Cyclizes ... is "driven" to completion. A protective agent for ... in many other preparations. Blocks the lethal and ... titration. Contaminants: Heavy metals: ≤1 ppm. ...
... recent sequencing of Salmonella genomes has allowed ... ORFmer PCR* primer pairs. The S. enterica ... single chromosome (4,857,432 bp; 4,440 ORFs) and ... These ORFmers from Sigma-Genosys have been designed ...
Biology Products: